Sectors
JBIO
Jade Biosciences, Inc.
20.36
1 x 20.18
1 x 20.53
bid
ask
-
0.17
0.83%
10:04 AM
timesize
| Ytd | 31.95% | |
| 1y | 126.73% |
20.04
day range
20.38
6.67
52 week range
28.00
| Open | 20.36 | Prev Close | 20.53 | Low | 20.04 | High | 20.38 | Mkt Cap | 669.81M |
| Vol | 55.02K | Avg Vol | 1.05M | EPS | -2.02 | P/E | -10.16 | Forward P/E | -9.86 |
| Beta | 1.43 | Short Ratio | 4.37 | Inst. Own | 82.98% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-14 | 50-d Avg | 20.56 | 200-d Avg | 16.08 | 1yr Est | 48.50 |
| Income Statement | |||
| Operating Expenses | 43.45M | ||
| Research and Development Expense | 36.05M | ||
| Selling, General and Administrative Expense | 7.39M | ||
| Operating Income | -43.44M | ||
| Income Tax Expense | 16.00K | ||
| Net Income | -40.37M | ||
| Net Income Common Stock | -40.37M | ||
| Net Income Common Stock (USD) | -40.37M | ||
| Consolidated Income | -40.37M | ||
| Earnings per Basic Share | -0.57 | ||
| Earnings per Basic Share (USD) | -0.57 | ||
| Earnings per Diluted Share | -0.57 | ||
| Earning Before Interest & Taxes (EBIT) | -40.35M | ||
| Earning Before Interest & Taxes (USD) | -40.35M | ||
| Weighted Average Shares | 57.78M | ||
| Weighted Average Shares Diluted | 57.78M | ||
| Balance Sheet | |||
| Cash and Equivalents | 55.09M | ||
| Cash and Equivalents (USD) | 55.09M | ||
| Investments | 256.21M | ||
| Investments Current | 256.21M | ||
| Current Assets | 318.52M | ||
| Property, Plant & Equipment Net | 847.00K | ||
| Total Assets | 319.43M | ||
| Total Debt | 679.00K | ||
| Current Liabilities | 22.29M | ||
| Debt Non-Current | 679.00K | ||
| Total Liabilities | 22.97M | ||
| Accumulated Retained Earnings (Deficit) | -214.76M | ||
| Accumulated Other Comprehensive Income | -342.00K | ||
| Shareholders Equity | 296.46M | ||
| Shareholders Equity (USD) | 296.46M | ||
| Assets Non-Current | 916.00K | ||
| Total Debt (USD) | 679.00K | ||
| Liabilities Non-Current | 679.00K | ||
| Trade and Non-Trade Payables | 3.98M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 35.00K | ||
| Net Cash Flow from Financing | -795.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -33.35M | ||
| Issuance (Purchase) of Equity Shares | -795.00K | ||
| Net Cash Flow from Investing | -8.47M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -8.47M | ||
| Net Cash Flow from Operations | -24.08M | ||
| Effect of Exchange Rate Changes on Cash | -7.00K | ||
| Share Based Compensation | 7.41M | ||